Please assess the completion status of the following clinical trial:

Trial Title: Bupivacaine, Levobupivacaine and Ropivacaine After Intrathecal and Extradural Injection in Labour

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* The patient is aged \> 18 years~* The patient is in early labour ≤ 5cm cervical dilatation~* The patient is American Association of Anaesthesiologists Grade I - II~* The patient provides written informed consent to participate in the trial prior to surgery~Exclusion Criteria:~* The patient has any known chronic medical condition for which regular medication is required~* The patient has received any investigational drug within the 90 days prior to the study or is scheduled to receive one during the study period~* The patient is scheduled for caesarean section~* The patient has received opioids in the last 4 hours~* The patient has evidence of alcohol or drug abuse~* There is evidence of obstetric complications~* The fetus has shown signs of intrauterine growth retardation~* The patient has findings on pre-study evaluations (e.g. laboratory results, medical history, physical examination, ECG) that are clinically significant in the investigator's opinion such to exclude entry into the study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Extradural bupivacaine (Type: ACTIVE_COMPARATOR): Local anesthetic
- Extradural levobupivacaine (Type: ACTIVE_COMPARATOR): local anaesthetic
- Extradural ropivacaine (Type: ACTIVE_COMPARATOR): local anaesthetic
- Intrathecal bupivacaine (Type: ACTIVE_COMPARATOR): local anaesthetic
- Intrathecal levobupivacaine (Type: ACTIVE_COMPARATOR): local anaesthetic
- Intrathecal ropivacaine (Type: ACTIVE_COMPARATOR): local anesthetic

Based on this trial design, predict the completion outcome and termination type (if applicable).